Responding to COVID-19

At AmerisourceBergen and through our family of companies, we ensure that crucial medications efficiently, reliably and securely reach their destinations every day. We recognize that our work is essential in advancing the treatment and prevention of COVID-19 and are dedicated to supporting our team members, customers, partners and patients at this critical time for healthcare. 

Addressing COVID-19

Treatment and prevention

We’re committed to being the best partner to support ongoing developments in the treatment and prevention of COVID-19.

Safety of our team members

The health, safety and well-being of our team members is a top priority during this global pandemic.

Business continuity

Our customers rely on us in order to treat and care for their patients which means it is paramount that we ensure any disruptions to our operations do not impact our ability to deliver on our customers’ needs.

Product availability and market disruption

We continue to apply innovation to ensure a stable supply of medicines to sites of care.

Partnerships

Responding to a global pandemic, including planning for the distribution of treatment and prevention therapies for COVID-19, takes a coordinated effort.

AmerisourceBergen Foundation support

In alignment with the Foundation’s mission, grant donations have been deployed to regional, national and global organizations focused on combatting the economic, psychosocial and health challenges resulting from the pandemic.

AmerisourceBergen Foundation and Family Reach

"A Financial Guide to COVID-19"

Free, downloadable guidebook for practices and patients, offering advice about managing the financial struggles that often follow a serious diagnosis or job loss.
Concerned family

Besse Medical's response to COVID-19

Information and resources for our customers

As the scale of the COVID-19 pandemic became apparent to physicians, manufacturers and the public alike, we provided these invaluable resources, webinars, and information.

Insight

New Provider Relief Fund Distributions


AmerisourceBergen
September 2021

HHS

Insight

HHS Provider Relief Fund reporting deadline approaching


Besse Medical
September 2021

Medical professional using manometer on a patient

Insight

US Department of Labor's OSHA issues Emergency Temporary Standard to protect healthcare workers from coronavirus


Besse Medical
June 2021

US Capitol

Insight

HHS issues revised notice of reporting requirements and reporting timeline for recipients of Provider Relief Fund payments


Besse Medical
June 2021

Doctor looks at laptop and takes notes

Insight

How to thrive with telemedicine

IntrinsiQ Specialty Solutions
Besse Medical
August 2020

Doctor talking to patient

Insight

The now normal, part 3: Proactive communications for practice success

Alana Vaughn
Besse Medical
July 2020

On-demand webinar #3

The road ahead for community practices

On-demand webinar #2

Minimizing the impact of COVID-19 on practice operations

On-demand webinar #1

Working together in response to COVID-19

Thoughts from our CEO

Executive Perspectives

Simple access to COVID vaccines creates unprecedented logistical complexity
 

Coronavirus Report

The Hill's Steve Clemmons interviews Steve Collis

 

Treatment and Prevention

We’re committed to being the best partner to support ongoing developments in the treatment and prevention of COVID-19.

130,950

Square ft of dedicated refrigerated storage space

16,240

Square ft of dedicated frozen storage space

150

Ultra-low temperature freezers

Media Statement on Federal Retail Pharmacy Program

With the start of the Federal Retail Pharmacy Program, AmerisourceBergen will formally begin its role as a “network administrator” and place orders with the U.S. Centers for Disease Control and Prevention (CDC) on behalf of an initial set of eligible and qualified Good Neighbor Pharmacy and Elevate Provider Network members in certain areas.

Innomar Strategies Reaches Agreement with the Government of Canada to Support COVID-19 Vaccine Distribution

Update on the distribution of Veklury® (Remdesivir) from Gilead Sciences

AmerisourceBergen is working with U.S. Department of Health and Human Services (HHS) in distributing COVID-19 therapies approved for Emergency Use Authorization (EUA)

AmerisourceBergen Reaches Agreement with CDC to Support Independent Community Pharmacies’ Access to COVID-19 Vaccine


 

Safety of our team members

The health, safety and well-being of our team members is a top priority during this global pandemic. We're supporting our front-line employees during COVID-19 with:
  • Enhanced cleaning protocol including EPA-approved disinfectants and additional support from third-party cleaners
  • Implemented "Wally" the UV disinfection robot in our distribution centers to ensure maximum cleanliness and team member safety
  • Back-up dependent care program
  • Enhanced paid time off policy for team members needing to self-quarantine or care for family members
 

Business continuity

Our customers rely on us in order to treat and care for their patients which means it is paramount that we ensure any disruptions to our operations do not impact our ability to deliver on our customers’ needs.

Product availability & market disruption

We continue to apply innovation to ensure a stable supply of medicines to sites of care.

How do allocations work for the pharma supply chain?

Three facts about how distributors are managing in-demand inventory.

Essential Medicines Strategic Stockpile Act of 2020

We are supporting legislation to ensure a stable supply of essential medicines for all Americans.

What I've Learned Leading AmerisourceBergen's COVID-19 Task Force

A letter from Heather Zenk, SVP, Strategic Global Sourcing

“It is better for patients and for the security of the supply chain to maintain inventory at the distributor level, rather than concentrate too many resources at any one site of care. This helps ensure the pharmaceutical supply chain's flexibility and responsiveness.”

Heather Zenk

SVP, Strategic Global Sourcing
 

Partnerships

Responding to a global pandemic, including planning for the distribution of treatment and prevention therapies for COVID-19, takes a coordinated effort. We continue to strengthen our public-private partnerships to support the pharmaceutical supply chain in addressing the COVID crisis.

Featured news

Media mention

How COVID-19 Strengthened the Supply Chain and Key Takeaways for the Future

Heather Zenk, PharmD
May 19, 2021

CMS fact sheet

2021 Special Enrollment Period in response to the COVID-19 emergency

Treasury press release

Treasury and IRS guidance on deductibility of expenses

Press release

Chronically Simple app enhanced to meet the COVID-19 challenges of the medically vulnerable

April 2020

Press release

The AmerisourceBergen Foundation commits global support to aid communities, individuals and team members impacted by COVID-19 

March 2020

Related Insights

Insight

Patient support in the time of COVID-19: Five ways to adapt


Lash Group
July 2020

Insight

How Do Allocations Work for the Pharma Supply Chain?

Heather Zenk, RPh, PharmD
AmerisourceBergen
April 2020

pharmacist in mask

Insight

COVID-19 and long-term care: An action plan for responding to a positive coronavirus test

Marc Johnson
AmerisourceBergen
August 2020